Alcohol Use Disorder: A Medical Condition That Deserves Evidence-Based Care

Alcohol Use Disorder (AUD) is not simply a lack of discipline. It is a medically recognized condition involving neurobiology, reward pathways, stress response, and behavioral reinforcement. Many people with AUD are highly functional, employed, and responsible in other areas of life—yet still experience cycles of craving, loss of control, and negative consequences.

AUD can range from mild to severe. It may present as:

• frequent heavy drinking
• difficulty cutting back
• cravings and compulsive use
• withdrawal symptoms
• continued use despite health or relationship harm
• repeated failed attempts to stop

Importantly, AUD is treatable. Many people improve significantly with structured support, and medication can be a meaningful part of a recovery plan for selected patients.

This page provides a Discover-safe educational overview of AUD treatment options, including non-controlled medications such as naltrexone and disulfiram, and explains how telemedicine can support safe screening, treatment planning, and ongoing monitoring.

Why Alcohol Use Disorder Requires Medical Screening

Alcohol affects multiple organ systems, and long-term heavy use can contribute to:

• liver inflammation and liver disease
• high blood pressure and cardiomyopathy
• sleep disruption
• depression and anxiety worsening
• cognitive impairment
• increased accident and injury risk
• medication interactions
• increased cancer risk over time

AUD treatment should include medical assessment to ensure:

• withdrawal risk is evaluated
• medications are safe for the patient
• mental health needs are addressed
• long-term care planning is realistic

Alcohol Withdrawal: When Telemedicine Is Not Enough

Alcohol withdrawal can be dangerous. Some patients can stop safely without medical detox, but others are at risk for severe withdrawal.

Withdrawal risk may be higher if:

• drinking is heavy and daily
• there is history of withdrawal symptoms
• there is history of seizures
• there is history of delirium tremens (DTs)
• there are serious medical comorbidities

Severe withdrawal requires in-person medical care.
Telemedicine should not be used to manage high-risk withdrawal.

This is a critical safety boundary in ethical AUD care.

Treatment Goals: Abstinence vs Reduction

AUD treatment is not “one-size-fits-all.” Clinicians often discuss goals such as:

Abstinence

Some patients want to stop completely and maintain long-term sobriety.

Reduction / Harm Reduction

Some patients aim to reduce heavy drinking episodes and regain control.

Both approaches can be clinically meaningful depending on:

• severity
• withdrawal risk
• medical comorbidities
• patient history and preference

Medication selection can differ depending on the goal.

Evidence-Based AUD Treatment: What Works Best

AUD outcomes improve when treatment includes:

1) Medication (when appropriate)

Medications can reduce cravings, reduce reinforcement, or support abstinence.

2) Behavioral support

This can include therapy, coaching, group support, or structured recovery planning.

3) Follow-up and monitoring

AUD is a chronic condition. Follow-up reduces relapse risk and supports long-term success.

Telemedicine can strengthen follow-up continuity.

How Alcohol Use Disorder Telemedicine Works at eSupport Health

At eSupport Health, AUD care is structured around safety, confidentiality, and evidence-based monitoring.

Step 1 — Structured Intake and Alcohol Use History

Patients provide:

• drinking frequency and quantity
• binge patterns and triggers
• prior quit attempts
• withdrawal history
• medical history (especially liver disease)
• current medications and supplements
• mental health screening (depression/anxiety)
• opioid use history (critical for naltrexone safety)

Step 2 — Clinical Review and Risk Screening

A licensed clinician evaluates:

• withdrawal risk and whether in-person detox is needed
• medical contraindications
• medication interaction risks
• whether telemedicine management is appropriate
• need for labs (especially liver function)

Step 3 — Treatment Planning

When clinically appropriate, a clinician may recommend:

• naltrexone or disulfiram therapy
• a structured reduction or abstinence plan
• relapse prevention strategies
• follow-up schedule and monitoring plan

Step 4 — Follow-Up and Long-Term Support

Follow-up supports:

• craving reduction monitoring
• side effect management
• adherence and motivation support
• mental health symptom tracking
• escalation and referral when needed

Medications in This Category

Your Alcohol Use Disorder category includes:

• Disulfiram (Antabuse)
• Naltrexone (Revia)

Both are non-controlled medications, but they are used differently and require different safety screening.

Naltrexone (Revia): Reducing Cravings and Reinforcement

Naltrexone is a medication used to support AUD treatment by reducing the rewarding effects of alcohol and decreasing cravings in many patients.

How it works (simplified)

Naltrexone blocks opioid receptors involved in reward signaling. For some patients, this can:

• reduce craving intensity
• reduce the “high reward” feeling from drinking
• support reduction or abstinence goals

Who may benefit

Naltrexone may be considered for patients who:

• have strong cravings
• experience binge patterns
• want support reducing heavy drinking
• want medication support for abstinence maintenance

Critical safety point: opioid use

Naltrexone cannot be used in patients currently using opioids. It can precipitate withdrawal and is unsafe in that context. Clinicians screen carefully for:

• opioid prescriptions
• illicit opioid use
• opioid dependence history

Liver considerations

Naltrexone is metabolized in the liver. Clinicians review:

• liver history
• lab values when indicated
• heavy alcohol-related liver injury risk

Disulfiram (Antabuse): Supporting Abstinence Through Deterrence

Disulfiram is used differently than naltrexone. It does not reduce cravings directly. Instead, it creates an unpleasant physiologic reaction if alcohol is consumed.

How it works (simplified)

Disulfiram blocks alcohol metabolism at a specific step, leading to buildup of acetaldehyde if alcohol is consumed. This can cause:

• flushing
• nausea
• headache
• rapid heart rate
• significant discomfort

This deterrent effect can help some patients maintain abstinence—particularly when:

• motivation is high
• a structured support system is present
• adherence is consistent
• patients understand alcohol avoidance requirements

Why disulfiram requires strict counseling

Patients must avoid alcohol in:

• beverages
• some mouthwashes
• some cough syrups
• certain products containing alcohol

Disulfiram therapy should only be used when the patient can reliably avoid alcohol exposure and understands safety risks.

Who may benefit

Disulfiram may be considered for patients who:

• have a clear abstinence goal
• prefer a deterrent-based strategy
• have a supportive environment
• can adhere consistently

Choosing Between Naltrexone and Disulfiram

Clinicians select medication based on:

Patient goals

• reduction vs abstinence

Medical history

• liver function
• cardiovascular risk
• psychiatric history
• medication list and interactions

Risk profile

• opioid use history (naltrexone safety)
• adherence reliability (disulfiram effectiveness)

Prior response

• what has worked previously
• side effect tolerability

Both medications require clinician oversight. Neither is appropriate as a casual “online prescription.”

Monitoring: What Clinicians Track in AUD Treatment

AUD treatment success is measured by functional improvement—not just abstinence days.

Clinicians often track:

• drinking frequency and quantity trends
• craving intensity
• sleep quality and mood stability
• work and relationship functioning
• relapse triggers and risk periods
• medication side effects and adherence
• lab monitoring when indicated (especially liver function)

Follow-up visits are essential because AUD is often cyclical and stress-sensitive.

Mental Health and AUD: The Two-Way Relationship

AUD commonly overlaps with:

• anxiety
• depression
• trauma history
• insomnia
• ADHD
• chronic stress and burnout

Sometimes alcohol use is a coping strategy. When alcohol decreases, underlying anxiety or depression may become more visible.

A responsible treatment plan includes:

• mental health screening
• monitoring during early recovery
• referral when therapy or psychiatric care is needed

This is one reason telemedicine follow-up is valuable.

Privacy and Confidentiality in AUD Care

Many patients avoid AUD care due to stigma. Confidentiality is essential.

A privacy-first telemedicine model includes:

• secure communications
• HIPAA-aligned record handling
• discreet documentation practices
• professional, non-judgmental clinical approach

This improves engagement and long-term outcomes.

Frequently Asked Questions (FAQ)